Dose-finding and Safety Study of PVSRIPO Against Recurrent WHO Grade IV Malignant Glioma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
March 5, 2020
End Date
July 24, 2022
Administered By
Duke Cancer Institute
Awarded By
Istari Oncology
Start Date
March 5, 2020
End Date
July 24, 2022